LakeShore Biopharma Co., Ltd (LSB)
Automate Your Wheel Strategy on LSB
With Tiblio's Option Bot, you can configure your own wheel strategy including LSB - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol LSB
- Rev/Share 20.4846
- Book/Share 39.4031
- PB 0.1329
- Debt/Equity 0.7253
- CurrentRatio 1.1258
- ROIC -0.2372
- MktCap 215852793.8437
- FreeCF/Share 0.0
- PFCF 0.0
- PE -0.2974
- Debt/Assets 0.2805
- DivYield 0
- ROE -0.4936
- Rating
- Score
- Recommendation
- P/E Score
- DCF Score
- P/B Score
- D/E Score
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
LakeShore Biopharma Announces Fiscal Year 2025 Financial Results
Published: July 31, 2025 by: PRNewsWire
Sentiment: Neutral
Total revenue reached RMB615.0 million, representing 7.2% year-over-year growth Gross profit rose to RMB507.2 million, up 11.3% year-over-year Gross margin improved to 82.5% from 79.5% in Fiscal Year 2024 Total operating expenses decreased 34.2% year-over-year to RMB593.5 million EBITDA[1] and Adjusted EBITDA[2] were RMB(48.5 million) and RMB0.6 million, respectively, compared to RMB(368.7 million) and RMB(236.4 million) in Fiscal Year 2024 Net loss narrowed to RMB100.0 million, with an adjusted net loss[3] of RMB40.0 million, compared to RMB433.5 million and RMB266.3 million, respectively, in Fiscal Year 2024 BEIJING , July 31, 2025 /PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore …
Read More
LakeShore Biopharma Announces the Official Launch of a Novel Packaging Solution for YSJA™ Rabies Vaccine (Vero Cell)
Published: April 23, 2025 by: PRNewsWire
Sentiment: Neutral
Revolutionizing Vaccination Safety with Needle-Free Reconstitution Technology BEIJING , April 23, 2025 /PRNewswire/ -- On April 18, 2025, LakeShore Biopharma Co., Ltd. (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company") successfully held the 2025 CSO ("Contract Sales Organization") Annual Meeting and the launch meeting of YSJA™ rabies vaccine (Vero cell) novel packaging solution (liquid drug transfer device) in Changsha, Hunan Province.
Read More
About LakeShore Biopharma Co., Ltd (LSB)
- IPO Date 2021-08-05
- Website https://www.ysbiopharm.com
- Industry Biotechnology
- CEO Wang Xu
- Employees 758